Pfizer submits data to FDA for kid COVID vaccine

  • 3 years ago
Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.

Recommended